These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34848562)

  • 1. LECT-2 amyloidosis: what do we know?
    Mann BK; Bhandohal JS; Cobos E; Chitturi C; Eppanapally S
    J Investig Med; 2022 Feb; 70(2):348-353. PubMed ID: 34848562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal leukocyte chemokine type 2 amyloidosis: a clinicopathological analysis of fifteen cases].
    Wang XY; Han WX; Chen SY; Niu D; Wang XY; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):809-815. PubMed ID: 39103262
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients.
    Li DY; Liu D; Wang SX; Yu XJ; Cui Z; Zhou FD; Zhao MH
    Amyloid; 2020 Jun; 27(2):134-141. PubMed ID: 32024381
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population.
    de la Cruz Jasso MA; Mejía-Vilet JM; Del Toro-Cisneros N; Aguilar-León DE; Morales-Buenrostro LE; Herrera G; Uribe-Uribe NO
    Am J Clin Pathol; 2023 Jan; 159(1):89-97. PubMed ID: 36370056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
    Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
    Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis.
    Chandan VS; Shah SS; Lam-Himlin DM; Petris GD; Mereuta OM; Dogan A; Torbenson MS; Wu TT
    Am J Surg Pathol; 2015 Apr; 39(4):558-64. PubMed ID: 25602789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
    Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
    Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically occult amyloidosis derived from leukocyte chemotactic factor 2 (ALECT 2) with cardiac involvement complicating renal transplantation: case report and literature review.
    Eletta O; Ali M; Grieff A; Puri S; Matsuda K; Bongu A; Fyfe B
    Cardiovasc Pathol; 2021; 55():107375. PubMed ID: 34371188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo leukocyte chemotactic factor 2 amyloidosis in a pediatric renal allograft, 15 years post-transplant.
    Shamir ER; Lee MM; Walavalkar V
    Pediatr Transplant; 2019 May; 23(3):e13371. PubMed ID: 30714275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte Cell-Derived Chemotaxin-2 Amyloidosis (ALECT2) in a Patient With Lung Adenocarcinoma: An Autopsy Report and Literature Review.
    Tariq H; Sharkey FE
    Int J Surg Pathol; 2018 May; 26(3):271-275. PubMed ID: 29017384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal amyloidosis: an update on diagnosis and pathogenesis.
    Gupta N; Kaur H; Wajid S
    Protoplasma; 2020 Sep; 257(5):1259-1276. PubMed ID: 32447467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukocyte chemotactic factor 2 associated renal amyloidosis: one case report].
    Wang Y; Wang SX; Zhang YK
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):349-51. PubMed ID: 25882959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALECT2 amyloidosis: a new type of systemic amyloid highly prevalent in the Hispanic population.
    Jiménez-Zepeda VH; Leung N
    Rev Invest Clin; 2014; 66(3):269-73. PubMed ID: 25695244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.
    Larsen CP; Ismail W; Kurtin PJ; Vrana JA; Dasari S; Nasr SH
    Mod Pathol; 2016 Apr; 29(4):416-20. PubMed ID: 26867784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report.
    Xu H; Jia Y; Wang X; Wang H; Yu J; Hao W
    Medicine (Baltimore); 2022 Jul; 101(29):e29638. PubMed ID: 35866785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
    Law S; Gillmore J; Gilbertson JA; Bass P; Salama AD
    BMC Nephrol; 2020 Feb; 21(1):74. PubMed ID: 32111193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.
    Larsen CP; Kossmann RJ; Beggs ML; Solomon A; Walker PD
    Kidney Int; 2014 Aug; 86(2):378-82. PubMed ID: 24522497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Immunoglobulin Amyloidosis-Mediated Kidney Disease: Emerging Understanding of Underdiagnosed Entities.
    Karam S; Kaushal A; Abu Amer N; Royal V; KItchlu A
    Adv Kidney Dis Health; 2024 Jul; 31(4):334-345. PubMed ID: 39084759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.